Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

Use of sacituzumab govitecan safe, efficacious in pretreated mBC
10 giờ trước
bởiStephen Padilla
A recent China study has provided further evidence on the real-world efficacy and safety of sacituzumab govitecan (SG) in HR+/HER2- and triple-negative breast cancer (TNBC) patients who have received at least three lines of prior therapy.
Use of sacituzumab govitecan safe, efficacious in pretreated mBC
10 giờ trước
Sacituzumab govitecan proves real-world survival benefits in metastatic breast cancer
một ngày trước
bởiStephen Padilla
A real-world study of the antibody-drug conjugate (ADC) sacituzumab govitecan in patients with HR+/ HER2- metastatic breast cancer (mBC) or metastatic triple-negative breast cancer (mTNBC) shows consistent survival outcomes as those seen in clinical trials.







